RIKER LAUREN bought PCRX
October 8, 2026 · Form 4 insider transaction
RIKER LAUREN bought 6,000 shares of Pacira BioSciences, Inc. at $32.35 per share, a transaction worth $194.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$32.35
Total value
$194.1K
InsiderRIKER LAUREN
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 8, 2026
Filing dateOctober 9, 2026
Shares owned after68,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026.